Landscape of FGF/FGFR Alterations in 12,372 Chinese Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Landscape of FGF/FGFR Alterations in 12,372 Chinese Cancer Patients

Published:2020 Issue:22 Volume:11 Page:6695-6699
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Zuo Wei,He Yan,Li Wei,Wu Hao,Zhao Zhengyi,Zhang Yuzi,Chen Shiqing,Yin Yongmei

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial;BMC Cancer;2024-08-13

2. A Comprehensive Analysis of FGF/FGFRSignaling Alteration in NSCLC：Implications in Prognosis and Microenvironment;2024

3. Infigratinib, a Selective Fibroblast Growth Factor Receptor Inhibitor, Suppresses Stent-Induced Tissue Hyperplasia in a Rat Esophageal Model;CardioVascular and Interventional Radiology;2023-07-25

4. Epidemiology, treatments, and related biomarkers of locally advanced or metastatic urothelial carcinoma in Chinese population: A scoping review;Cancer Medicine;2023-06-30

5. Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors;Cancer Science;2022-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP